Keywords: astrazeneca, partially, divests, cv, drugs, searle, acquired

AstraZeneca partially divests two CV drugs

Article | 28 October 1999

Searle has acquired the rights to two cardiovascular drugs, SelokenComp (metoprolol and hydrochlorothiazide) and Tenormin (atenolol), from AstraZeneca for certain ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Astra Zeneca

AstraZeneca

Go to company listing

Related Drugs

Atenolol Tablets

Tenormin

Go to drug listing